Coloplast cuts China staff as recovery stalls
Coloplast has reduced its Chinese commercial workforce by 80 employees amid weak demand and rising domestic competition. The Danish medical device maker does not expect business in the region to stabilize before the 2027 or 2028 financial year.
Insights:
Denmark-based medical device maker Coloplast cut 80 commercial jobs in China on Tuesday morning after sales slowed. The move addresses mounting pressure from domestic competitors and weak consumer demand for ostomy care products. Operations in the region will not stabilize until the 2027/28 financial period, management said.
